Navigation Links
Research Volunteer Registry from Verified Clinical Trials Adopted by ICON
Date:12/17/2012

Garden City, New York (PRWEB) December 17, 2012

Verified Clinical Trials today announced that ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, is using its research volunteer registry in its Clinical Pharmacology units in the US to ensure volunteer safety and clinical data quality.

The Verified Clinical Trials online registry, currently available in the US and Canada, prevents multiple trial enrollment and premature re-enrollment into another study by a research subject. The clinical research database volunteer registry safeguards data integrity and patient safety without delaying the screening process by ensuring that only qualified research subjects are enrolled in a study.

Dr. Mitchell D. Efros, CEO of Verified Clinical Trials, stated "ICON is one of the world's largest and most prominent leaders in the clinical trial business and their adoption of the Verified Clinical Trials registry significantly strengthens our network. By utilizing Verified Clinical Trials, ICON has further demonstrated its commitment to providing high quality clinical research data. Verified Clinical Trials continues to partner with many of the world's largest CROs and pharmaceutical companies in the world."

“Simultaneous study enrollment places the health of the volunteer at risk and may compromise the integrity of clinical data,” commented Mario Rocci, President, ICON Development Solutions. “The Verified Clinical Trials volunteer clinical research database registry allows us to maintain our high standards of data quality and patient safety and improves our ability to enroll qualified research subjects in a timely manner.”

ICON will use the Verified Clinical Trials volunteer registry in its Clinical Pharmacology units located in San Antonio, Texas and Omaha, Nebraska.

About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous other value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, RSVP or visit verifiedclinicaltrials.com.

Media Contacts
Verified Clinical Trials
Kerri Weingard, Chief Operating Officer, Verified Clinical Trials
Tel: +1 516 998-7499
KWeingard(at)verifiedclinicaltrials(dot)com

Read the full story at http://www.prweb.com/releases/2012/12/prweb10240744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
(Date:5/22/2016)... ... May 22, 2016 , ... Doctors in Rome say micronutrients found ... cancer, malignant mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... Rome’s Department of Clinical Sciences and Translational Medicine evaluated more than 150 studies on ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in Ashland, Virginia ... is complete. The new structure adds a third office building to the current facilities. ... purchased 2.4 acres of land, along with office space adjacent to the previous main ...
(Date:5/19/2016)... MADRID , May 19, 2016 ... di una sessione orale durante il 52 ° ... (abstract n. 8006)    - Le conclusioni ... quanto riguarda i pazienti trattati, di cui il 90% presenta ... di sei mesi o più. Il settantadue per cento dei ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):